The Universal Credit and Employment and Support Allowance (Claimant Commitment Exceptions) (Amendment) Regulations 2022
Citation, commencement and extent1.
(1)
These Regulations may be cited as the Universal Credit and Employment and Support Allowance (Claimant Commitment Exceptions) (Amendment) Regulations 2022 and come into force on 15th February 2022.
(2)
Any amendment made by these Regulations has the same extent as the provision amended.
Amendment to the Universal Credit Regulations 20132.
(a)
regulation 16 shall stand as paragraph (1);
(b)
“(2)
A person does not have to meet the basic condition to have accepted a claimant commitment if the person is terminally ill.”.
Amendment to the Employment and Support Allowance Regulations 20133.
(a)
regulation 45 shall stand as paragraph (1);
(b)
“(2)
A claimant may be entitled to an employment and support allowance without having accepted a claimant commitment if the claimant is terminally ill.”.
Signed by authority of the Secretary of State for Work and Pensions
These Regulations amend the Universal Credit Regulations 2013 (S.I. 2013/376) (“the UC Regulations”) and the Employment and Support Allowance Regulations 2013 (S.I. 2013/379) (“the ESA Regulations”) by setting out an additional exception to the requirement to accept a claimant commitment which is a condition of entitlement.
Regulation 16 of the UC Regulations and regulation 45 of the ESA Regulations contain two exceptions to the requirement to accept a claimant commitment, that is, where the Secretary of State considers that a person lacks capacity to accept a claimant commitment and where there are exceptional circumstances in which it would be unreasonable to expect a person to accept a claimant commitment. These Regulations provide an additional exception which exempts terminally ill claimants from the requirement to accept a claimant commitment. “Terminally ill” is defined in regulation 2 of the UC Regulations and regulation 2 of the ESA Regulations and means suffering from a progressive disease where death in consequence of that disease can reasonably be expected within 6 months.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, public or voluntary sectors is foreseen.